<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32840822</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research.</ArticleTitle><Pagination><StartPage>5084</StartPage><EndPage>5102</EndPage><MedlinePgn>5084-5102</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-020-02059-1</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a multifactorial and progressive neurodegenerative disease of unknown etiology. Due to ALS's unpredictable onset and progression rate, the search for biomarkers that allow the detection and tracking of its development and therapeutic efficacy would be of significant medical value. Considering that alterations of energy supply are one of ALS's main hallmarks and that a correlation has been established between gene expression in human brain tissue and peripheral blood mononuclear cells (PBMCs), the present work investigates whether changes in mitochondrial function could be used to monitor ALS. To achieve this goal, PBMCs from ALS patients and control subjects were used; blood sampling is a quite non-invasive method and is cost-effective. Different parameters were evaluated, namely cytosolic calcium levels, mitochondrial membrane potential, oxidative stress, and metabolic compounds levels, as well as mitochondrial dynamics and degradation. Altogether, we observed lower mitochondrial calcium uptake/retention, mitochondria depolarization, and redox homeostasis deregulation, in addition to a decrease in critical metabolic genes, a diminishment in mitochondrial biogenesis, and an augmentation in mitochondrial fission and autophagy-related gene expression. All of these changes can contribute to the decreased ATP and pyruvate levels observed in ALS PBMCs. Our data indicate that PBMCs from ALS patients show a significant mitochondrial dysfunction, resembling several findings from ALS' neural cells/models, which could be exploited as a powerful tool in ALS research. Our findings can also guide future studies on new pharmacological interventions for ALS since assessments of brain samples are challenging and represent a relevant limited strategy. Graphical abstract.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Araujo</LastName><ForeName>Beatriz Grisolia</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Department of Physiological Science, Santa Casa de S&#xe3;o Paulo School of Medical Science, Rua Doutor Ces&#xe1;rio Motta J&#xfa;nior, 61 - Vila Buarque, S&#xe3;o Paulo, SP, CEP 01221-020, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza E Silva</LastName><ForeName>Luiz Felipe</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Physiological Science, Santa Casa de S&#xe3;o Paulo School of Medical Science, Rua Doutor Ces&#xe1;rio Motta J&#xfa;nior, 61 - Vila Buarque, S&#xe3;o Paulo, SP, CEP 01221-020, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Barros Torresi</LastName><ForeName>Jorge Luiz</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Physiological Science, Santa Casa de S&#xe3;o Paulo School of Medical Science, Rua Doutor Ces&#xe1;rio Motta J&#xfa;nior, 61 - Vila Buarque, S&#xe3;o Paulo, SP, CEP 01221-020, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siena</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiological Science, Santa Casa de S&#xe3;o Paulo School of Medical Science, Rua Doutor Ces&#xe1;rio Motta J&#xfa;nior, 61 - Vila Buarque, S&#xe3;o Paulo, SP, CEP 01221-020, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valerio</LastName><ForeName>Berenice Cataldo Oliveira</ForeName><Initials>BCO</Initials><AffiliationInfo><Affiliation>Department of Neurology, Irmandade da Santa Casa de Miseric&#xf3;rdia de S&#xe3;o Paulo, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brito</LastName><ForeName>Mariana Dutra</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Physiological Science, Santa Casa de S&#xe3;o Paulo School of Medical Science, Rua Doutor Ces&#xe1;rio Motta J&#xfa;nior, 61 - Vila Buarque, S&#xe3;o Paulo, SP, CEP 01221-020, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenstock</LastName><ForeName>Tatiana Rosado</ForeName><Initials>TR</Initials><Identifier Source="ORCID">0000-0003-1153-7412</Identifier><AffiliationInfo><Affiliation>Department of Physiological Science, Santa Casa de S&#xe3;o Paulo School of Medical Science, Rua Doutor Ces&#xe1;rio Motta J&#xfa;nior, 61 - Vila Buarque, S&#xe3;o Paulo, SP, CEP 01221-020, Brazil. tati.farm@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2015/02041-1</GrantID><Agency>Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo</Agency><Country/></Grant><Grant><GrantID>2018/09084-6</GrantID><Agency>Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo</Agency><Country/></Grant><Grant><GrantID>2015/25595-2</GrantID><Agency>Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo</Agency><Country/></Grant><Grant><GrantID>2016/12039-7</GrantID><Agency>Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo</Agency><Country/></Grant><Grant><GrantID>2017-2019</GrantID><Agency>FAP Santa Casa</Agency><Country/></Grant><Grant><GrantID>2018-2020</GrantID><Agency>FAP Santa Casa</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063154" MajorTopicYN="Y">Mitochondrial Dynamics</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001678" MajorTopicYN="Y">Organelle Biogenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biogenesis</Keyword><Keyword MajorTopicYN="N">Mitochondrial depolarization</Keyword><Keyword MajorTopicYN="N">Mitochondrial fission</Keyword><Keyword MajorTopicYN="N">Patients</Keyword><Keyword MajorTopicYN="N">Peripheral blood mononuclear cells</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32840822</ArticleId><ArticleId IdType="pmc">PMC7541388</ArticleId><ArticleId IdType="doi">10.1007/s12035-020-02059-1</ArticleId><ArticleId IdType="pii">10.1007/s12035-020-02059-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Seetharaman SV, Prudencio M, Karch C, et al. Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis. Exp Biol Med. 2009;234(10):1140&#x2013;1154. doi: 10.3181/0903-MR-104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0903-MR-104</ArticleId><ArticleId IdType="pmc">PMC2850267</ArticleId><ArticleId IdType="pubmed">19596823</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alessandro G, Calcagno E, Tartari S, et al. Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism. Neurobiol Dis. 2011;43(2):346&#x2013;355. doi: 10.1016/j.nbd.2011.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.04.003</ArticleId><ArticleId IdType="pubmed">21530659</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Jones A, Troakes C, et al. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 2012;124(3):339&#x2013;352. doi: 10.1007/s00401-012-1022-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1022-4</ArticleId><ArticleId IdType="pubmed">22903397</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Schulte DJ, et al. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin. 2015;33(4):855&#x2013;876. doi: 10.1016/j.ncl.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, et al. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol. 2015;6:171. doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo F, Mirra A, Carr&#xec; MT. Oxidative stress and mitochondrial damage in the pathogenesis of ALS: new perspectives. Neurosci Lett. 2017;636:3&#x2013;8. doi: 10.1016/j.neulet.2016.04.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.04.065</ArticleId><ArticleId IdType="pubmed">27150074</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 2018;135(4):489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito MD, da Silva GFG, Tilieri EM, et al. Metabolic alteration and amyotrophic lateral sclerosis outcome: a systematic review. Front Neurol. 2019;10:1205. doi: 10.3389/fneur.2019.01205.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01205</ArticleId><ArticleId IdType="pmc">PMC6879457</ArticleId><ArticleId IdType="pubmed">31824397</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripps ME, Huntley GW, Hof PR, et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 1995;92:689&#x2013;693. doi: 10.1073/pnas.92.3.689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.3.689</ArticleId><ArticleId IdType="pmc">PMC42685</ArticleId><ArticleId IdType="pubmed">7846037</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi P, Gal J, Kwinter DM, et al. Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim Biophys Acta. 2010;1802:45&#x2013;51. doi: 10.1016/j.bbadis.2009.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2009.08.012</ArticleId><ArticleId IdType="pmc">PMC2790551</ArticleId><ArticleId IdType="pubmed">19715760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladd AC, Keeney PM, Govind MM, et al. Mitochondrial oxidative phosphorylation transcriptome alterations in human amyotrophic lateral sclerosis spinal cord and blood. NeuroMolecular Med. 2014;16(4):714&#x2013;726. doi: 10.1007/s12017-014-8321-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-014-8321-y</ArticleId><ArticleId IdType="pubmed">25081190</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Rajan S, Duffy L, et al. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiol Aging. 2014;35(6):1499&#x2013;1509. doi: 10.1016/j.neurobiolaging.2013.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.025</ArticleId><ArticleId IdType="pubmed">24439480</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; MT, Valle C, Bozzo F, et al. Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Front Neurosci. 2015;9:41. doi: 10.3389/fncel.2015.00041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00041</ArticleId><ArticleId IdType="pmc">PMC4330888</ArticleId><ArticleId IdType="pubmed">25741238</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferriere F, Polymenidou M (2015) Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis. Swiss Med Wkly 145(0506). 10.4414/smw.2015.14054</Citation><ArticleIdList><ArticleId IdType="pubmed">25635517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadenbach B (2012) Introduction to mitochondrial oxidative phosphorylation. Adv Exp Med Biol Springer, New York, NY 1&#x2013;11. 10.1007/978-1-4614-3573-0_1.</Citation><ArticleIdList><ArticleId IdType="pubmed">22729852</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Z, Ristow M. Mitochondria and metabolic homeostasis. Antioxid Redox Signal. 2013;8:240&#x2013;242. doi: 10.1089/ars.2013.5255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5255</ArticleId><ArticleId IdType="pubmed">23432475</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz TL. Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol. 2013;5(6):a011304. doi: 10.1101/cshperspect.a011304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a011304</ArticleId><ArticleId IdType="pmc">PMC3660831</ArticleId><ArticleId IdType="pubmed">23732472</ArticleId></ArticleIdList></Reference><Reference><Citation>Osellame LD, Duchen MR. Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration. B J Pharmacol. 2014;171(8):1958&#x2013;1972. doi: 10.1111/bph.12453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12453</ArticleId><ArticleId IdType="pmc">PMC3976615</ArticleId><ArticleId IdType="pubmed">24116849</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Kukreti R, Saso L, et al. Oxidative stress: a key modulator in neurodegenerative. Dis Mol. 2019;24(8):1583. doi: 10.3390/molecules24081583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24081583</ArticleId><ArticleId IdType="pmc">PMC6514564</ArticleId><ArticleId IdType="pubmed">31013638</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira FG, Ping Q, Moreno AJ, et al. Guanabenz treatment accelerates disease in a mutant SOD1 mouse model of ALS. PLoS One. 2015;10(8):e0135570. doi: 10.1371/journal.pone.0135570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135570</ArticleId><ArticleId IdType="pmc">PMC4545826</ArticleId><ArticleId IdType="pubmed">26288094</ArticleId></ArticleIdList></Reference><Reference><Citation>Shook SJ, Pioro EP. Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient. Ann Neurol. 2009;65(S1):S10&#x2013;S16. doi: 10.1002/ana.21545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21545</ArticleId><ArticleId IdType="pubmed">19191305</ArticleId></ArticleIdList></Reference><Reference><Citation>Paillisse C, Lacomblez L, Dib M, et al. Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6(1):37&#x2013;44. doi: 10.1080/14660820510027035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510027035</ArticleId><ArticleId IdType="pubmed">16036424</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, di Scala F, Rene F, et al. Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis. FASEB J. 2003;17(14):2091&#x2013;2093. doi: 10.1096/fj.02-1182fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.02-1182fje</ArticleId><ArticleId IdType="pubmed">14500553</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5&#x2013;6):310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, K&#xfc;hnlein P, Hendrich C, et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011;258(4):613&#x2013;617. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja NA, Van Der Schouw YT, Fischer K, et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(6):638&#x2013;642. doi: 10.1136/jnnp.2010.236752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.236752</ArticleId><ArticleId IdType="pubmed">21471184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda Y, Sciarretta S, Nagarajan N, et al. New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart. Oxidative Med Cell Longev. 2014;2014:210934. doi: 10.1155/2014/210934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/210934</ArticleId><ArticleId IdType="pmc">PMC4124219</ArticleId><ArticleId IdType="pubmed">25132912</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Zhang M, Z&#xe1;rate AQ, et al. Uric acid levels predict survival in men with amyotrophic lateral sclerosis. J Neurol. 2012;259(9):1923&#x2013;1928. doi: 10.1007/s00415-012-6440-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6440-7</ArticleId><ArticleId IdType="pmc">PMC4441749</ArticleId><ArticleId IdType="pubmed">22323210</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YM, Gupta SK, Kim KJ, et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Stem Cells. 2013;12(6):713&#x2013;726. doi: 10.1016/j.stem.2013.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.04.003</ArticleId><ArticleId IdType="pmc">PMC3707511</ArticleId><ArticleId IdType="pubmed">23602540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Battistini S, Calvo A, et al. Genetic counselling in ALS: facts, uncertainties and clinical suggestions. J Neurol Neurosurg Psychiatry. 2014;85(5):478&#x2013;485. doi: 10.1136/jnnp-2013-305546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-305546</ArticleId><ArticleId IdType="pubmed">23833266</ArticleId></ArticleIdList></Reference><Reference><Citation>Creemers H, Grupstra H, Nollet F, et al. Prognostic factors for the course of functional status of patients with ALS: a systematic review. J Neurol. 2015;262(6):1407&#x2013;1423. doi: 10.1007/s00415-014-7564-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7564-8</ArticleId><ArticleId IdType="pubmed">25385051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda C, Leoni E, Milani P, et al. Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis. PLoS One. 2013;8(10):e75916. doi: 10.1371/journal.pone.0075916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075916</ArticleId><ArticleId IdType="pmc">PMC3796534</ArticleId><ArticleId IdType="pubmed">24155874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, Macdonald-Wallis C, Gray E, et al. Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. J Neurol. 2015;84(22):2247&#x2013;2257. doi: 10.1212/WNL.0000000000001642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001642</ArticleId><ArticleId IdType="pmc">PMC4456658</ArticleId><ArticleId IdType="pubmed">25934855</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Garcon G, Patin F, et al. Panel of oxidative stress and inflammatory biomarkers in ALS: a pilot study. Can J Neurol Sci. 2017;44(1):90&#x2013;95. doi: 10.1017/cjn.2016.284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2016.284</ArticleId><ArticleId IdType="pubmed">27774920</ArticleId></ArticleIdList></Reference><Reference><Citation>Copped&#xe8; F, Stoccoro A, Mosca L, et al. Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutations. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(1&#x2013;2):93&#x2013;101. doi: 10.1080/21678421.2017.1367401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1367401</ArticleId><ArticleId IdType="pubmed">28859526</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber NS, Shepheard SR, Sassani M, et al. Biomarkers in motor neuron disease: a state of the art review. Front Neurol. 2019;10:291. doi: 10.3389/fneur.2019.00291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00291</ArticleId><ArticleId IdType="pmc">PMC6456669</ArticleId><ArticleId IdType="pubmed">31001186</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin D, Thompson MA, Nadler JV. The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur J Pharmacol. 1993;250(3):473&#x2013;476. doi: 10.1016/0014-2999(93)90037-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(93)90037-I</ArticleId><ArticleId IdType="pubmed">8112408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(3):261&#x2013;268. doi: 10.1002/ajmg.b.30272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.30272</ArticleId><ArticleId IdType="pubmed">16526044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5&#x2013;6):291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mota SI, Costa RO, Ferreira IL, et al. Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer&#x2019;s disease. Biochim Biophys Acta. 2015;1852(7):1428&#x2013;1441. doi: 10.1016/j.bbadis.2015.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.03.015</ArticleId><ArticleId IdType="pubmed">25857617</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho ACP, Sharpe J, Rosenstock TR, et al. Bax affects intracellular Ca 2+ stores and induces Ca 2+ wave propagation. Cell Death Differ. 2004;11(12):1265. doi: 10.1038/sj.cdd.4401508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401508</ArticleId><ArticleId IdType="pubmed">15499375</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenstock TR, Carvalho ACP, Jurkiewicz A, et al. Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. J Neurochem. 2004;88:1220&#x2013;1228. doi: 10.1046/j.1471-4159.2003.02250.x1220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.02250.x1220</ArticleId><ArticleId IdType="pubmed">15009678</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenstock TR, Bertoncini CRA, Teles AV, et al. Glutamate-induced alterations in Ca2+ signaling are modulated by mitochondrial Ca2+ handling capacity in brain slices of R6/1 transgenic mice. Eur J Neurosci. 2010;32(1):60&#x2013;70. doi: 10.1111/j.1460-9568.2010.07268.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2010.07268.x</ArticleId><ArticleId IdType="pubmed">20608968</ArticleId></ArticleIdList></Reference><Reference><Citation>Naia L, Ferreira IL, Cunha-Oliveira T, et al. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington&#x2019;s disease human lymphoblasts. Mol Neurobiol. 2015;51(1):331&#x2013;348. doi: 10.1007/s12035-014-8735-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8735-4</ArticleId><ArticleId IdType="pubmed">24841383</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto EC, Colombrita V, Gumina MO, et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol Commun. 2016;4(1):47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro M, Rosenstock TR, Cunha-Oliveira T, et al. Glutathione redox cycle dysregulation in Huntington&#x2019;s disease knock-in striatal cells. Free Radic Biol Med. 2012;53(10):1857&#x2013;1867. doi: 10.1016/j.freeradbiomed.2012.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2012.09.004</ArticleId><ArticleId IdType="pubmed">22982598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro M, Rosenstock TR, Oliveira AM, et al. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington&#x2019;s disease knock-in striatal cells. Free Radic Biol Med. 2014;74:129&#x2013;144. doi: 10.1016/j.freeradbiomed.2014.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.06.023</ArticleId><ArticleId IdType="pubmed">24992836</ArticleId></ArticleIdList></Reference><Reference><Citation>Naia L, Ribeiro M, Rodrigues J, et al. Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin. Neuropeptides. 2016;58:73&#x2013;81. doi: 10.1016/j.npep.2016.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.npep.2016.01.009</ArticleId><ArticleId IdType="pubmed">26876526</ArticleId></ArticleIdList></Reference><Reference><Citation>Naia L, Cunha-Oliveira T, Rodrigues J, et al. Histone deacetylase inhibitors protect against pyruvate dehydrogenase dysfunction in Huntington&#x2019;s disease. J Neurosci. 2017;37(10):2776&#x2013;2794. doi: 10.1523/JNEUROSCI.2006-14.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2006-14.2016</ArticleId><ArticleId IdType="pmc">PMC6596633</ArticleId><ArticleId IdType="pubmed">28123081</ArticleId></ArticleIdList></Reference><Reference><Citation>Naia L, Rosenstock TR, Oliveira AM, et al. Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in Huntington&#x2019;s disease models. Mol Neurobiol. 2017;54(7):5385&#x2013;5399. doi: 10.1007/s12035-016-0048-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0048-3</ArticleId><ArticleId IdType="pubmed">27590140</ArticleId></ArticleIdList></Reference><Reference><Citation>E Silva LFS, Brito MD, Yuzawa JMC, et al. Mitochondrial dysfunction and changes in high-energy compounds in different cellular models associated to hypoxia: implication to schizophrenia. Sci Rep. 2019;9(1):18049. doi: 10.1038/s41598-019-53605-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-53605-4</ArticleId><ArticleId IdType="pmc">PMC6889309</ArticleId><ArticleId IdType="pubmed">31792231</ArticleId></ArticleIdList></Reference><Reference><Citation>Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor &#x3b3; coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006;27(7):728&#x2013;735. doi: 10.1210/er.2006-0037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2006-0037</ArticleId><ArticleId IdType="pubmed">17018837</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Pineda VV, Torrence AE, et al. Thermoregulatory and metabolic defects in Huntington&#x2019;s disease transgenic mice implicate PGC-1&#x3b1; in Huntington&#x2019;s disease neurodegeneration. Cell Metab. 2006;4(5):349&#x2013;362. doi: 10.1016/j.cmet.2006.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2006.10.004</ArticleId><ArticleId IdType="pubmed">17055784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys. 2007;462:245&#x2013;253. doi: 10.1016/j.abb.2007.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2007.03.034</ArticleId><ArticleId IdType="pmc">PMC2756107</ArticleId><ArticleId IdType="pubmed">17475204</ArticleId></ArticleIdList></Reference><Reference><Citation>Copple IM, Goldring CE, Kitteringham NR, et al. The Nrf2&#x2013;Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology. 2008;246(1):24&#x2013;33. doi: 10.1016/j.tox.2007.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2007.10.029</ArticleId><ArticleId IdType="pubmed">18083283</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol. 2008;445:77&#x2013;88. doi: 10.1007/978-1-59745-157-4_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-59745-157-4_4</ArticleId><ArticleId IdType="pubmed">18425443</ArticleId></ArticleIdList></Reference><Reference><Citation>Handschin C. The biology of PGC-1&#x3b1; and its therapeutic potential. Trends Pharmacol Sci. 2009;30(6):322&#x2013;329. doi: 10.1016/j.tips.2009.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2009.03.006</ArticleId><ArticleId IdType="pubmed">19446346</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsunaga K, Saitoh T, Tabata K, et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol. 2009;11(4):385. doi: 10.1038/ncb1846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1846</ArticleId><ArticleId IdType="pubmed">19270696</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein DC, Cuervo AM, Ravikumar B, et al. In search of an &#x201c;autophagomometer&#x201d;. Autophagy. 2009;5:585&#x2013;589. doi: 10.4161/auto.5.5.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5.5.8823</ArticleId><ArticleId IdType="pubmed">19411822</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q, Fan W, Zhong Q. Regulation of Beclin 1 in autophagy. Autophagy. 2009;5(5):713&#x2013;716. doi: 10.1073/pnas.0810452105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810452105</ArticleId><ArticleId IdType="pmc">PMC2789700</ArticleId><ArticleId IdType="pubmed">19372752</ArticleId></ArticleIdList></Reference><Reference><Citation>Osellame LD, Blacker TS, Duchen MR. Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab. 2012;26(6):711&#x2013;723. doi: 10.1016/j.beem.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem</ArticleId><ArticleId IdType="pmc">PMC3513836</ArticleId><ArticleId IdType="pubmed">23168274</ArticleId></ArticleIdList></Reference><Reference><Citation>Venegas V, Halberg MC. Measurement of mitochondrial DNA copy number. Methods Mol Biol. 2012;837:327&#x2013;335. doi: 10.1007/978-1-61779-504-6_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-504-6_22</ArticleId><ArticleId IdType="pubmed">22215558</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Chandrasekaran K, Inoue T, et al. PGC-1&#x3b1; regulation of mitochondrial degeneration in experimental diabetic neuropathy. Neurobiol Dis. 2014;64:118&#x2013;130. doi: 10.1016/j.nbd.2014.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC4023837</ArticleId><ArticleId IdType="pubmed">24423644</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Soyal SM, Landwehrmeyer GB, et al. A single nucleotide polymorphism in the coding region of PGC-1&#x3b1; is a male-specific modifier of Huntington disease age-at-onset in a large European cohort. BMC Neurol. 2014;14(1):1. doi: 10.1186/1471-2377-14-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-14-1</ArticleId><ArticleId IdType="pmc">PMC3880172</ArticleId><ArticleId IdType="pubmed">24383721</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Rydzewski N, Hider A, et al. A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation. Nat Cell Biol. 2016;18(4):404. doi: 10.1038/ncb3324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3324</ArticleId><ArticleId IdType="pmc">PMC4871318</ArticleId><ArticleId IdType="pubmed">26950892</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer H, Lang K, Buck E, et al. ALS-causing mutations differentially affect PGC-1&#x3b1; expression and function in the brain vs. peripheral tissues. Neurobiol Dis. 2017;97:36&#x2013;45. doi: 10.1016/j.nbd.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016</ArticleId><ArticleId IdType="pubmed">27818323</ArticleId></ArticleIdList></Reference><Reference><Citation>King GA, Hashemi Shabestari M, Taris KKH, et al. Acetylation and phosphorylation of human TFAM regulate TFAM&#x2013;DNA interactions via contrasting mechanisms. Nucleic Acids Res. 2018;46(7):3633&#x2013;3642. doi: 10.1093/nar/gky204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky204</ArticleId><ArticleId IdType="pmc">PMC5909435</ArticleId><ArticleId IdType="pubmed">29897602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyama T, Chen CK, Wang SW, et al. Essential roles of mitochondrial biogenesis regulator Nrf1 in retinal development and homeostasis. Mol Neurodegener. 2018;13(1):56. doi: 10.1186/s13024-018-0287-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0287-z</ArticleId><ArticleId IdType="pmc">PMC6192121</ArticleId><ArticleId IdType="pubmed">30333037</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212; &#x394;&#x394;CT method. Methods. 2001;25(4):402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccanti M, Onesti E, Rubino A, et al. Modulation of human corticospinal excitability by paired associative stimulation in patients with amyotrophic lateral sclerosis and effects of Riluzole. Brain Stimul. 2018;11(4):775&#x2013;781. doi: 10.1016/j.brs.2018.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2018.02.007</ArticleId><ArticleId IdType="pubmed">29459142</ArticleId></ArticleIdList></Reference><Reference><Citation>Crompton M, Barksby E, Johnson N, et al. Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie. 2002;84(2&#x2013;3):143&#x2013;152. doi: 10.1016/S0300-9084(02)01368-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0300-9084(02)01368-8</ArticleId><ArticleId IdType="pubmed">12022945</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnaiger E. Mitochondrial pathways and respiratory control. An introduction to OXPHOS analysis Mitochondr. Physiol Network. 4. 2007. pp. 19&#x2013;80.</Citation></Reference><Reference><Citation>Huang H, Tu R, Liu F, et al. Effects of resveratrol on Nrf2 signal pathway of chronic lead-exposed mouse brain tissue. Wei Sheng Yan Jiu. 2015;44(6):954&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pubmed">26738390</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Meng XF, Zhang C. Role of NADPH oxidase-mediated reactive oxygen species in podocyte injury. Biomed Res Int. 2013;2013:839761. doi: 10.1155/2013/839761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/839761</ArticleId><ArticleId IdType="pmc">PMC3844218</ArticleId><ArticleId IdType="pubmed">24319690</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinkova-Kostova AT, Kazantsev AG. Activation of Nrf2 signaling as a common treatment of neurodegenerative diseases. Neurodegener Dis. 2017;7(2):97&#x2013;100. doi: 10.2217/nmt-2017-0011.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt-2017-0011</ArticleId><ArticleId IdType="pubmed">28534719</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Knowlton AA. Repetitive ROS injury leads to inactivation of NRF2-induced antioxidant defense and mitochondrial dysfunction in ischemic heart failure. FASEB J. 2016;31(1_supplement):1080.19-1080.19. doi: 10.1096/fasebj.31.1_supplement.1080.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.31.1_supplement.1080.19</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales Pantoja IE, Hu CL, Perrone-Bizzozero NI, et al. Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis. J Neurochem. 2016;139(4):640&#x2013;650. doi: 10.1111/jnc.13837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13837</ArticleId><ArticleId IdType="pmc">PMC5118114</ArticleId><ArticleId IdType="pubmed">27579494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RY, Liu LH, Liu H, et al. Nrf2 protects against diabetic dysfunction of endothelial progenitor cells via regulating cell senescence. Int J Mol Med. 2018;42(3):1327&#x2013;1340. doi: 10.3892/ijmm.2018.3727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2018.3727</ArticleId><ArticleId IdType="pmc">PMC6089760</ArticleId><ArticleId IdType="pubmed">29901179</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang WT, Chen HI, Chiou RJ, et al. A novel function of transcription factor &#x3b1;-Pal/NRF-1: Increasing neurite outgrowth. Biochem Biophys Res Commun. 2005;334(1):199&#x2013;206. doi: 10.1016/j.bbrc.2005.06.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.06.079</ArticleId><ArticleId IdType="pubmed">15992771</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CH, Wang CC, Wei YH. Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Ann N Y Acad Sci. 2010;1201(1):157&#x2013;165. doi: 10.1111/j.1749-6632.2010.05625.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2010.05625.x</ArticleId><ArticleId IdType="pubmed">20649552</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson NG, Wang J, Wilhelmsson H, et al. Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice. Nat Genet. 1998;18(3):231. doi: 10.1038/ng0398-231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0398-231</ArticleId><ArticleId IdType="pubmed">9500544</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapaport D, Neupert W. Biogenesis of Tom40, core component of the TOM complex of mitochondria. J Cell Biol. 1999;146(2):321&#x2013;331. doi: 10.1083/jcb.146.2.321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.146.2.321</ArticleId><ArticleId IdType="pmc">PMC2156174</ArticleId><ArticleId IdType="pubmed">10427088</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes A, Mezzina M, Gadaleta G. Human mitochondrial transcription factor A (mtTFA): gene structure and characterization of related pseudogenes. Gene. 2002;291(1&#x2013;2):223&#x2013;232. doi: 10.1016/S0378-1119(02)00600-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-1119(02)00600-5</ArticleId><ArticleId IdType="pubmed">12095695</ArticleId></ArticleIdList></Reference><Reference><Citation>Facucho-Oliveira JM, Alderson J, Spikings EC, et al. Mitochondrial DNA replication during differentiation of murine embryonic stem cells. J Cell Sci. 2007;120(22):4025&#x2013;4034. doi: 10.1242/jcs.016972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.016972</ArticleId><ArticleId IdType="pubmed">17971411</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Soyal SM, Gellera C, et al. The gene coding for PGC-1&#x3b1; modifies age at onset in Huntington&#x2019;s disease. Mol Neurodegener. 2009;4(1):3. doi: 10.1186/1750-1326-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-4-3</ArticleId><ArticleId IdType="pmc">PMC2630305</ArticleId><ArticleId IdType="pubmed">19133136</ArticleId></ArticleIdList></Reference><Reference><Citation>Taherzadeh-Fard E, Saft C, Akkad DA, et al. PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Mol Neurodegener. 2011;6(1):32. doi: 10.1186/1750-1326-6-32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-32</ArticleId><ArticleId IdType="pmc">PMC3117738</ArticleId><ArticleId IdType="pubmed">21595933</ArticleId></ArticleIdList></Reference><Reference><Citation>Lezza AM. Mitochondrial transcription factor A (TFAM): one actor for different roles. Front Biol. 2012;7(1):30&#x2013;39. doi: 10.1007/s11515-011-1175-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11515-011-1175-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo HB, Lovely GA, Phillips R, et al. Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation. Nat Commun. 2014;5:3077. doi: 10.1038/ncomms4077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4077</ArticleId><ArticleId IdType="pmc">PMC3936014</ArticleId><ArticleId IdType="pubmed">24435062</ArticleId></ArticleIdList></Reference><Reference><Citation>Novin MG, Allahveisi A, Noruzinia M, et al. The relationship between transcript expression levels of nuclear encoded (TFAM, NRF1) and mitochondrial encoded (MT-CO1) genes in single human oocytes during oocyte maturation. Balkan J Med Genet. 2015;18(1):39&#x2013;46. doi: 10.1515/bjmg-2015-0004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bjmg-2015-0004</ArticleId><ArticleId IdType="pmc">PMC4768824</ArticleId><ArticleId IdType="pubmed">26929904</ArticleId></ArticleIdList></Reference><Reference><Citation>Novin MG, Noruzinia M, Allahveisi A, et al. Comparison of mitochondrial-related transcriptional levels of TFAM, NRF1 and MT-CO1 genes in single human oocytes at various stages of the oocyte maturation. Iran Biomed J. 2015;19(1):23. doi: 10.6091/ibj.1400.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.6091/ibj.1400.2015</ArticleId><ArticleId IdType="pmc">PMC4322229</ArticleId><ArticleId IdType="pubmed">25605486</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebasti&#xe1;n D, Zorzano A. Mitochondrial dynamics and metabolic homeostasis. Curr Opin Physiol. 2018;3:34&#x2013;40. doi: 10.1016/j.cophys.2018.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cophys.2018.02.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Li Y, Liu X, et al. Mitochondrial dynamics modulation as a critical contribution for Shenmai injection in attenuating hypoxia/reoxygenation injury. J Ethnopharmacol. 2019;37:9&#x2013;19. doi: 10.1016/j.jep.2019.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2019.03.033</ArticleId><ArticleId IdType="pubmed">30880258</ArticleId></ArticleIdList></Reference><Reference><Citation>Los&#xf3;n OC, Song Z, Chen H, et al. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell. 2013;24(5):659&#x2013;667. doi: 10.1091/mbc.E12-10-0721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E12-10-0721</ArticleId><ArticleId IdType="pmc">PMC3583668</ArticleId><ArticleId IdType="pubmed">23283981</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AU, Saw NL, Vogel H, et al. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. EMBO Mol Med. 2018;10(3):e8166. doi: 10.15252/emmm.201708166.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708166</ArticleId><ArticleId IdType="pmc">PMC5840540</ArticleId><ArticleId IdType="pubmed">29335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Manczak M, Kandimalla R, Yin X, et al. Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity. Hum Mol Genet. 2018;28(2):177&#x2013;199. doi: 10.1093/hmg/ddy335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy335</ArticleId><ArticleId IdType="pmc">PMC6322070</ArticleId><ArticleId IdType="pubmed">30239719</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamacher-Brady A, Brady NR. Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell Mol Life Sci. 2016;73(4):775&#x2013;795. doi: 10.1007/s00018-015-2087-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-015-2087-8</ArticleId><ArticleId IdType="pmc">PMC4735260</ArticleId><ArticleId IdType="pubmed">26611876</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams JA, Ding WX. Mechanisms, pathophysiological roles and methods for analyzing mitophagy&#x2013;recent insights. Biol Chem. 2018;399(2):147&#x2013;178. doi: 10.1515/hsz-2017-0228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2017-0228</ArticleId><ArticleId IdType="pmc">PMC5835338</ArticleId><ArticleId IdType="pubmed">28976892</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang N, Li L, Chen S, et al. PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control. Cell Death Dis. 2016;7(12):e2501. doi: 10.1038/cddis.2016.396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2016.396</ArticleId><ArticleId IdType="pmc">PMC5261015</ArticleId><ArticleId IdType="pubmed">27906179</ArticleId></ArticleIdList></Reference><Reference><Citation>Truban D, Hou X, Caulfield TR, et al. PINK1, Parkin, and mitochondrial quality control: what can we learn about Parkinson&#x2019;s disease pathobiology? J Parkinsons Dis. 2017;7(1):13&#x2013;29. doi: 10.3233/JPD-160989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-160989</ArticleId><ArticleId IdType="pmc">PMC5302033</ArticleId><ArticleId IdType="pubmed">27911343</ArticleId></ArticleIdList></Reference><Reference><Citation>Seranova E, Palhegyi AM, Verma S, et al. Human induced pluripotent stem cell models of neurodegenerative disorders for studying the biomedical implications of autophagy. J Mol Biol. 2020;432(8):2754&#x2013;2798. doi: 10.1016/j.jmb.2020.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.01.024</ArticleId><ArticleId IdType="pubmed">32044344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Korolchuk VI, Renna M, et al. Complex inhibitory effects of nitric oxide on autophagy. Cell Mol. 2011;43(1):19&#x2013;32. doi: 10.1016/j.molcel.2011.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.04.029</ArticleId><ArticleId IdType="pmc">PMC3149661</ArticleId><ArticleId IdType="pubmed">21726807</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolz A, Ernst A, Dikic I. Cargo recognition and trafficking in selective autophagy. Nat Cell Biol. 2014;16(6):495. doi: 10.1016/j.jim.2014.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2014.06.007</ArticleId><ArticleId IdType="pubmed">24875736</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang WC, Wei Y, Kuo YC, et al. High-throughput screens to identify autophagy inducers that function by disrupting Beclin 1/Bcl-2 binding. ACS Chem Biol. 2018;13(8):2247&#x2013;2260. doi: 10.1021/acschembio.8b00421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.8b00421</ArticleId><ArticleId IdType="pmc">PMC6250051</ArticleId><ArticleId IdType="pubmed">29878747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft LJ, Dowler J, Manral P, et al. Size, organization, and dynamics of soluble SQSTM1 and LC3-SQSTM1 complexes in living cells. Autophagy. 2016;12(9):1660&#x2013;1674. doi: 10.1080/15548627.2016.1199299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1199299</ArticleId><ArticleId IdType="pmc">PMC5082789</ArticleId><ArticleId IdType="pubmed">27442348</ArticleId></ArticleIdList></Reference><Reference><Citation>Seranova E, Ward C, Chipara M, et al. In vitro screening platforms for identifying autophagy modulators in mammalian cells. Autophagy. 2019;1880:389&#x2013;428. doi: 10.1007/978-1-4939-8873-0_26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8873-0_26</ArticleId><ArticleId IdType="pubmed">30610712</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookes PS. Mitochondrial nitric oxide synthase. Mitochondrion. 2004;3(4):187&#x2013;204. doi: 10.1016/j.mito.2003.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2003.10.001</ArticleId><ArticleId IdType="pubmed">16120354</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona JC, Tapia R. Ca2+-permeable AMPA receptors and intracellular Ca2+ determine motoneuron vulnerability in rat spinal cord in vivo. Neuropharmacol. 2007;52(5):1219&#x2013;1228. doi: 10.1016/j.neuropharm.2006.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2006.12.008</ArticleId><ArticleId IdType="pubmed">17320918</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H, Manfredi G. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Mech Ageing Dev. 2010;131(7&#x2013;8):517&#x2013;526. doi: 10.1016/j.mad.2010.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2010.05.003</ArticleId><ArticleId IdType="pmc">PMC2933290</ArticleId><ArticleId IdType="pubmed">20493207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK. Calcium, mitochondria, and the pathogenesis of ALS: the good, the bad, and the ugly. Front Cell Neurosci. 2013;7:199. doi: 10.3389/fncel.2013.00199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00199</ArticleId><ArticleId IdType="pmc">PMC3813898</ArticleId><ArticleId IdType="pubmed">24198760</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2017;S0304-3940(17):30544&#x2013;3054X. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma M, Wills ZP, Chu CT. Excitatory dendritic mitochondrial calcium toxicity: implications for Parkinson&#x2019;s and other neurodegenerative diseases. Front Neurosci. 2018;12:523. doi: 10.3389/fnins.2018.00523.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00523</ArticleId><ArticleId IdType="pmc">PMC6083050</ArticleId><ArticleId IdType="pubmed">30116173</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK, Zech WD, Goos M, et al. Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease. BMC Neurosci. 2009;10:64. doi: 10.1186/1471-2202-10-64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-10-64</ArticleId><ArticleId IdType="pmc">PMC2716351</ArticleId><ArticleId IdType="pubmed">19545440</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadi&#x107; V, Adam A, Goldhammer N, et al. Investigation of mitochondrial calcium uniporter role in embryonic and adult motor neurons from G93AhSOD1 mice. Neurobiol Aging. 2019;75:209&#x2013;222. doi: 10.1016/j.neurobiolaging.2018.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.11.019</ArticleId><ArticleId IdType="pubmed">30597405</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Lewinski F, Fuchs J, Vanselow BK, et al. Low Ca2+ buffering in hypoglossal motoneurons of mutant SOD1 (G93A) mice. Neurosci Lett. 2008;445(3):224&#x2013;228. doi: 10.1016/j.neulet.2008.08.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2008.08.084</ArticleId><ArticleId IdType="pubmed">18782598</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdallah Y, Kasseckert SA, Iraqi W, et al. Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes. J Cell Mol Med. 2011;15(11):2478&#x2013;2485. doi: 10.1111/j.1582-4934.2010.01249.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2010.01249.x</ArticleId><ArticleId IdType="pmc">PMC3822958</ArticleId><ArticleId IdType="pubmed">21199327</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Sanz C, De la Fuente S, Sheu SS. Mitochondrial Ca2+ concentrations in live cells: quantification methods and discrepancies. FEBS Lett. 2019;593(13):1528&#x2013;1541. doi: 10.1002/1873-3468.13427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13427</ArticleId><ArticleId IdType="pmc">PMC7573507</ArticleId><ArticleId IdType="pubmed">31058316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (&#x394;&#x3c8; m) in apoptosis; an update. Apoptosis. 2003;8(2):115&#x2013;128. doi: 10.1023/A:10229451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:10229451</ArticleId><ArticleId IdType="pubmed">12766472</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazotte B. Labeling mitochondria with TMRM or TMRE. Cold Spring Harb Protoc. 2011;2011(7):pdb-prot5641. doi: 10.1101/pdb.prot5641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/pdb.prot5641</ArticleId><ArticleId IdType="pubmed">21724814</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassina P, Cassina A, Pehar M, et al. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci. 2008;28(16):4115&#x2013;4122. doi: 10.1523/JNEUROSCI.5308-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5308-07.2008</ArticleId><ArticleId IdType="pmc">PMC3844766</ArticleId><ArticleId IdType="pubmed">18417691</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava M, Vivekanandhan S, Pati U, et al. Mitochondrial perturbance and execution of apoptosis in platelet mitochondria of patients with amyotrophic lateral sclerosis. Int J Neurosci. 2011;121(3):149&#x2013;158. doi: 10.3109/00207454.2010.537416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2010.537416</ArticleId><ArticleId IdType="pubmed">21138397</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath PR, Shaw PJ. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26(4):438&#x2013;458. doi: 10.1002/mus.10186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10186</ArticleId><ArticleId IdType="pubmed">12362409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Wang J, Hu S, et al. BI1 alleviates cardiac microvascular ischemia-reperfusion injury via modifying mitochondrial fission and inhibiting XO/ROS/F-actin pathways. J Cell Physiol. 2019;234(4):5056&#x2013;5069. doi: 10.1002/jcp.27308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27308</ArticleId><ArticleId IdType="pubmed">30256421</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell B. Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition. Mutation Research/Genetic Toxic Environment Mutagen. 1999;443(1&#x2013;2):37&#x2013;52. doi: 10.1016/S1383-5742(99)00009-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1383-5742(99)00009-5</ArticleId><ArticleId IdType="pubmed">10415430</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010;48(5):629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico E, Factor-Litvak P, Santella RM, et al. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med. 2013;65:509&#x2013;527. doi: 10.1016/j.freeradbiomed.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond L, Bernhardt K, Madria P, et al. A metadata analysis of oxidative stress etiology in preclinical amyotrophic lateral sclerosis: benefits of antioxidant therapy. Front Neurosci. 2018;12:10. doi: 10.3389/fnins.2018.00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00010</ArticleId><ArticleId IdType="pmc">PMC5787557</ArticleId><ArticleId IdType="pubmed">29416499</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrera-Juli&#xe1; S, Moreno ML, Barrios C, et al. Antioxidant alternatives in the treatment of amyotrophic lateral sclerosis: a comprehensive review. Front Physiol. 2020;11:63. doi: 10.3389/fphys.2020.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00063</ArticleId><ArticleId IdType="pmc">PMC7016185</ArticleId><ArticleId IdType="pubmed">32116773</ArticleId></ArticleIdList></Reference><Reference><Citation>Curti D, Malaspina A, Facchetti G, et al. Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurol. 1996;47(4):1060&#x2013;1064. doi: 10.1212/WNL.47.4.1060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.4.1060</ArticleId><ArticleId IdType="pubmed">8857745</ArticleId></ArticleIdList></Reference><Reference><Citation>Oteiza PI, Uchitel OD, Carrasquedo F, et al. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amiotrophic lateral sclerosis patients. Neurol Res. 1997;22(4):535&#x2013;539. doi: 10.1023/a:1027384432715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1027384432715</ArticleId><ArticleId IdType="pubmed">9130267</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnefont-Rousselot D, Lacomblez L, Jaudon MC, et al. Blood oxidative stress in amyotrophic lateral sclerosis. J Neurol Sci. 2000;178(1):57&#x2013;62. doi: 10.1016/s0022-510x(00)00365-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(00)00365-8</ArticleId><ArticleId IdType="pubmed">11018250</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebay LE, Robertson H, Durant ST, et al. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med. 2015;88(Pt B):108&#x2013;146. doi: 10.1016/j.freeradbiomed.2015.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.06.021</ArticleId><ArticleId IdType="pmc">PMC4659505</ArticleId><ArticleId IdType="pubmed">26122708</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas MR, Pehar M, Cassina P, et al. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes consequences for motor neuron survival. J Biol Chem. 2005;280(27):25571&#x2013;25579. doi: 10.1074/jbc.M501920200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M501920200</ArticleId><ArticleId IdType="pubmed">15870071</ArticleId></ArticleIdList></Reference><Reference><Citation>Thau N, Knippenberg S, K&#xf6;rner S, et al. Decreased mRNA expression of PGC-1&#x3b1; and PGC-1&#x3b1;-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J Neuropathol Exp Neurol. 2012;71(12):1064&#x2013;1074. doi: 10.1097/NEN.0b013e318275df4b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318275df4b</ArticleId><ArticleId IdType="pubmed">23147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Zhang Y, Wen D, et al. The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model. Lab Investig. 2013;93(7):825. doi: 10.1038/labinvest.2013.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2013.73</ArticleId><ArticleId IdType="pubmed">23711824</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AP, Wada S, Vergani L, et al. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis. 2013;49:107. doi: 10.1016/j.nbd.2012.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.08.015</ArticleId><ArticleId IdType="pubmed">22975021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1&#x3b1;. Cardiovasc Res. 2008;79(2):208&#x2013;217. doi: 10.1093/cvr/cvn098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvn098</ArticleId><ArticleId IdType="pubmed">18430751</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo GM, Granatiero V, Kawamata H, et al. Parkin is a disease modifier in the mutant SOD1 mouse model of ALS. EMBO Mol Med. 2018;10(10):e8888. doi: 10.15252/emmm.201808888.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201808888</ArticleId><ArticleId IdType="pmc">PMC6180298</ArticleId><ArticleId IdType="pubmed">30126943</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandri M, Lin J, Handschin C, et al. PGC-1&#x3b1; protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci. 2006;103(44):16260&#x2013;16265. doi: 10.1073/pnas.0607795103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607795103</ArticleId><ArticleId IdType="pmc">PMC1637570</ArticleId><ArticleId IdType="pubmed">17053067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1&#x3b1;. Cell. 2006;127(6):1109&#x2013;1122. doi: 10.1016/j.cell.2006.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.11.013</ArticleId><ArticleId IdType="pubmed">17112576</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y, Yin X, Wang S, et al. PGC-1 silencing compounds the perturbation of mitochondrial function caused by mutant SOD1 in skeletal muscle of ALS mouse model. Front Aging Neurosci. 2015;7:204. doi: 10.3389/fnagi.2015.00204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00204</ArticleId><ArticleId IdType="pmc">PMC4611176</ArticleId><ArticleId IdType="pubmed">26539112</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel T. Cell biology: a clean energy programme. Nat Res. 2006;444(7116):151. doi: 10.1038/444151a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/444151a</ArticleId><ArticleId IdType="pubmed">17093435</ArticleId></ArticleIdList></Reference><Reference><Citation>St-Pierre J, Drori S, Uldry M, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006;127(2):397&#x2013;408. doi: 10.1016/j.cell.2006.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.09.024</ArticleId><ArticleId IdType="pubmed">17055439</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Xue H, Fang W, et al. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity. Redox Biol. 2019;21:101068. doi: 10.1016/j.redox.2018.101068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.101068</ArticleId><ArticleId IdType="pmc">PMC6351233</ArticleId><ArticleId IdType="pubmed">30684890</ArticleId></ArticleIdList></Reference><Reference><Citation>Virbasius JV, Scarpulla RC. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci U S A. 1994;91(4):1309&#x2013;1313. doi: 10.1073/pnas.91.4.1309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.4.1309</ArticleId><ArticleId IdType="pmc">PMC43147</ArticleId><ArticleId IdType="pubmed">8108407</ArticleId></ArticleIdList></Reference><Reference><Citation>Asin-Cayuela J, Gustafsson CM. Mitochondrial transcription and its regulation in mammalian cells. Trends Biochem Sci. 2007;32(3):111&#x2013;117. doi: 10.1016/j.tibs.2007.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2007.01.003</ArticleId><ArticleId IdType="pubmed">17291767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladd AC, Brohawn DG, Thomas RR, et al. RNA-seq analyses reveal that cervical spinal cords and anterior motor neurons from amyotrophic lateral sclerosis subjects show reduced expression of mitochondrial DNA-encoded respiratory genes, and rhTFAM may correct this respiratory deficiency. Brain Res. 2017;1667:74&#x2013;83. doi: 10.1016/j.brainres.2017.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2017.05.010</ArticleId><ArticleId IdType="pubmed">28511992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, Yoshida M, Yamato M, et al. Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor in mice. J Neurosci. 2008;28(34):8624&#x2013;8634. doi: 10.1523/JNEUROSCI.1957-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1957-08.2008</ArticleId><ArticleId IdType="pmc">PMC6671051</ArticleId><ArticleId IdType="pubmed">18716221</ArticleId></ArticleIdList></Reference><Reference><Citation>Florentz C, Sohm B, Tryoen-Toth P, et al. Human mitochondrial tRNAs in health and disease. Cell Mol Life Sci. 2003;60(7):1356&#x2013;1375. doi: 10.1007/s00018-003-2343-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-003-2343-1</ArticleId><ArticleId IdType="pubmed">12943225</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeney PM, Bennett JP. ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions. Mol Neurodegener. 2010;5(1):21. doi: 10.1186/1750-1326-5-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-5-21</ArticleId><ArticleId IdType="pmc">PMC2889994</ArticleId><ArticleId IdType="pubmed">20504367</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy PH. Mitochondrial dysfunction in aging and Alzheimer&#x2019;s disease: strategies to protect neurons. Antioxid Redox Signal. 2007;9(10):1647&#x2013;1658. doi: 10.1089/ars.2007.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2007.1754</ArticleId><ArticleId IdType="pubmed">17696767</ArticleId></ArticleIdList></Reference><Reference><Citation>Knott AB, Perkins G, Schwarzenbacher R, et al. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci. 2008;9(7):505. doi: 10.1038/nrn2417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2417</ArticleId><ArticleId IdType="pmc">PMC2711514</ArticleId><ArticleId IdType="pubmed">18568013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Zhu L, Qiu W, et al. Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activation of mitochondrial unfolded protein response signaling in the brain of ALS SOD1G93A mice. Int J Biol Sci. 2020;16(2):284&#x2013;297. doi: 10.7150/ijbs.38487.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.38487</ArticleId><ArticleId IdType="pmc">PMC6949147</ArticleId><ArticleId IdType="pubmed">31929756</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahani-Asl A, Cheung EC, Neuspiel M, et al. Mitofusin 2 protects cerebellar granule neurons against injury-induced cell death. J Biol Chem. 2007;282(33):23788&#x2013;23798. doi: 10.1074/jbc.M703812200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M703812200</ArticleId><ArticleId IdType="pubmed">17537722</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Wang L, Liu J, et al. Abnormalities of mitochondrial dynamics in neurodegenerative diseases. Antioxid. 2017;6(2):25. doi: 10.3390/antiox6020025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox6020025</ArticleId><ArticleId IdType="pmc">PMC5488005</ArticleId><ArticleId IdType="pubmed">28379197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Li L, Lin WL, et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet. 2013;22(23):4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Yang M, Chen Y, et al. FUS interacts with HSP60 to promote mitochondrial damage. PLoS Genet. 2015;11(9):e1005357. doi: 10.1371/journal.pgen.1005357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005357</ArticleId><ArticleId IdType="pmc">PMC4559378</ArticleId><ArticleId IdType="pubmed">26335776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Bordoni M, Drufuca L, et al. Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms. Dis Model Mech. 2018;11(3):dmm031625. doi: 10.1242/dmm.031625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.031625</ArticleId><ArticleId IdType="pmc">PMC5897724</ArticleId><ArticleId IdType="pubmed">29419416</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Yamashita T, Tian F, et al. Mitochondrial fusion and fission proteins expression dynamically change in a murine model of amyotrophic lateral sclerosis. Curr Neurovasc Res. 2013;10(3):222&#x2013;230. doi: 10.2174/15672026113109990060.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/15672026113109990060</ArticleId><ArticleId IdType="pubmed">23713734</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy PH, Reddy TP, Manczak M, et al. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Rev. 2011;67(1&#x2013;2):103&#x2013;118. doi: 10.1016/j.brainresrev.2010.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2010.11.004</ArticleId><ArticleId IdType="pmc">PMC3061980</ArticleId><ArticleId IdType="pubmed">21145355</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359&#x2013;407. doi: 10.1146/annurev.genet.39.110304.095751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.genet.39.110304.095751</ArticleId><ArticleId IdType="pmc">PMC2821041</ArticleId><ArticleId IdType="pubmed">16285865</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler S, Holmstr&#xf6;m KM, Skujat D, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol. 2010;12(2):119. doi: 10.1038/ncb2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2012</ArticleId><ArticleId IdType="pubmed">20098416</ArticleId></ArticleIdList></Reference><Reference><Citation>Okatsu K, Saisho K, Shimanuki M, et al. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cells. 2010;15(8):887&#x2013;900. doi: 10.1111/j.1365-2443.2010.01426.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2443.2010.01426.x</ArticleId><ArticleId IdType="pmc">PMC2970908</ArticleId><ArticleId IdType="pubmed">20604804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim GG, Chua DS, Basil AH, et al. Cytosolic PTEN-induced putative kinase 1 is stabilized by the NF-&#x3ba;B pathway and promotes non-selective mitophagy. J Biol Chem. 2015;290(27):16882&#x2013;16893. doi: 10.1096/fasebj.31.1_supplement.1080.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.31.1_supplement.1080.19</ArticleId><ArticleId IdType="pmc">PMC4505434</ArticleId><ArticleId IdType="pubmed">25987559</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra D, Tanaka A, Suen DF, et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183:795&#x2013;803. doi: 10.1083/jcb.200809125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200809125</ArticleId><ArticleId IdType="pmc">PMC2592826</ArticleId><ArticleId IdType="pubmed">19029340</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra D, Kane LA, Hauser DN, et al. p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy. 2010;6(8):1090&#x2013;1106. doi: 10.4161/auto.6.8.13426.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.8.13426</ArticleId><ArticleId IdType="pmc">PMC3359490</ArticleId><ArticleId IdType="pubmed">20890124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Hutt KR, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci. 2012;15(11):1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Stribl C, Samara A, Tr&#xfc;mbach D, et al. Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43. J Biol Chem. 2014;289(15):10769&#x2013;10784. doi: 10.1074/jbc.M113.515940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.515940</ArticleId><ArticleId IdType="pmc">PMC4036193</ArticleId><ArticleId IdType="pubmed">24515116</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto N, Nagai M, Ohta Y, et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007;1167:112&#x2013;117. doi: 10.1016/j.brainres.2007.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.06.045</ArticleId><ArticleId IdType="pubmed">17689501</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Zhang X, Le W. Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy. 2008;4(3):290&#x2013;293. doi: 10.4161/auto.5524.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5524</ArticleId><ArticleId IdType="pubmed">18196963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2011;70(5):349&#x2013;359. doi: 10.1097/NEN.0b013e3182160690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182160690</ArticleId><ArticleId IdType="pubmed">21487309</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Li L, Chen S, et al. Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7(4):412&#x2013;425. doi: 10.4161/auto.7.4.14541.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.7.4.14541</ArticleId><ArticleId IdType="pubmed">21193837</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M, Valenzuela V, Rojas-Rivera D, et al. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy. 2014;10(7):1256&#x2013;1271. doi: 10.4161/auto.28784.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.28784</ArticleId><ArticleId IdType="pmc">PMC4203551</ArticleId><ArticleId IdType="pubmed">24905722</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsui S, Otomo A, Nozaki M, et al. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1 H46R-expressing ALS mouse model. Mol Brain. 2018;11(1):30. doi: 10.1186/s13041-018-0373-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-018-0373-8</ArticleId><ArticleId IdType="pmc">PMC5975400</ArticleId><ArticleId IdType="pubmed">29843805</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzardini M, Mangolini A, Lupi M, et al. Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells. J Neurol Sci. 2005;232(1&#x2013;2):95&#x2013;103. doi: 10.1016/j.jns.2005.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.004</ArticleId><ArticleId IdType="pubmed">15850589</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne SE, Yang L, DiMauro JP, et al. Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis. 2006;22(3):599&#x2013;610. doi: 10.1016/j.nbd.2006.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.01.001</ArticleId><ArticleId IdType="pubmed">16616851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehinger JK, Morota S, Hansson MJ, et al. Mitochondrial dysfunction in blood cells from amyotrophic lateral sclerosis patients. J Neurol. 2015;262(6):1493&#x2013;1503. doi: 10.1007/s00415-015-7737-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7737-0</ArticleId><ArticleId IdType="pubmed">25893255</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Lepore E, Martini M, et al. Metabolic changes associated with muscle expression of SOD1G93A. Front Physiol. 2018;9:831. doi: 10.3389/fphys.2018.00831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00831</ArticleId><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera TW, Bartlett K, Tran SS, et al. Impaired pentose phosphate pathway in the spinal cord of the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. Mol Neurobiol. 2019;56(8):5844&#x2013;5855. doi: 10.1007/s12035-019-1485-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1485-6</ArticleId><ArticleId IdType="pubmed">30685842</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali Y, Zisapels N. Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase. Neurobiol Dis. 2008;32(1):133&#x2013;141. doi: 10.1016/j.nbd.2008.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.06.010</ArticleId><ArticleId IdType="pubmed">18652897</ArticleId></ArticleIdList></Reference><Reference><Citation>Valbuena GN, Rizzardini M, Cimini S, et al. Metabolomic analysis reveals increased aerobic glycolysis and amino acid deficit in a cellular model of amyotrophic lateral sclerosis. Mol Neurobiol. 2016;53(4):2222&#x2013;2240. doi: 10.1007/s12035-015-9165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9165-7</ArticleId><ArticleId IdType="pmc">PMC4823370</ArticleId><ArticleId IdType="pubmed">25963727</ArticleId></ArticleIdList></Reference><Reference><Citation>Veyrat-Durebex C, Bris C, Codron P, et al. Metabo-lipidomics of fibroblasts and mitochondrial-endoplasmic reticulum extracts from ALS patients shows alterations in purine, pyrimidine, energetic, and phospholipid metabolisms. Mol Neurobiol. 2019;56(8):5780&#x2013;5791. doi: 10.1007/s12035-019-1484-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1484-7</ArticleId><ArticleId IdType="pubmed">30680691</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;e A, Lecarpentier Y, Guillevin R, et al. Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington&#x2019;s disease. Rev Neurosci. 2018;29(5):547&#x2013;555. doi: 10.1515/revneuro-2017-0075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2017-0075</ArticleId><ArticleId IdType="pubmed">29303786</ArticleId></ArticleIdList></Reference><Reference><Citation>Josefsen K, Nielsen SM, Campos A, et al. Reduced gluconeogenesis and lactate clearance in Huntington&#x2019;s disease. Neurobiol Dis. 2010;40(3):656&#x2013;662. doi: 10.1016/j.nbd.2010.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.08.009</ArticleId><ArticleId IdType="pubmed">20727971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S, Torazza C, Bonifacino T, et al. Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS. J Neurochem. 2019;151(3):336&#x2013;350. doi: 10.1111/jnc.14819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14819</ArticleId><ArticleId IdType="pubmed">31282572</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;e A. Aerobic glycolysis activation through canonical WNT/&#x3b2;-catenin pathway in ALS. Med Sci (Paris) 2018;34(4):326&#x2013;330. doi: 10.1051/medsci/20183404013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1051/medsci/20183404013</ArticleId><ArticleId IdType="pubmed">29658475</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan BA, Killoy KM, Pehar M, et al. Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models. Exp Neurol. 2020;327:113219. doi: 10.1016/j.expneurol.2020.113219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113219</ArticleId><ArticleId IdType="pmc">PMC7089832</ArticleId><ArticleId IdType="pubmed">32014438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger VA. Controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L, Bensimon G, Leigh PN, et al. Doseranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347:1425&#x2013;1431. doi: 10.1016/S0140-6736(96)91680-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)91680-3</ArticleId><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi VB, Al-Chalabi A. Molecular insights and therapeutic targets in amyotrophic lateral sclerosis. CNS Neurol Disord Drug Targets. 2008;7:11&#x2013;19. doi: 10.2174/187152708783885110.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152708783885110</ArticleId><ArticleId IdType="pubmed">18289027</ArticleId></ArticleIdList></Reference><Reference><Citation>Li RW, Deng Y, Pham HN, et al. Riluzole protects against skeletal muscle ischaemia-reperfusion injury in a porcine model. Injury. 2020;51(2):178&#x2013;184. doi: 10.1016/j.injury.2019.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2019.12.030</ArticleId><ArticleId IdType="pubmed">31882236</ArticleId></ArticleIdList></Reference><Reference><Citation>Umemiya M, Berger AJ. Inhibition by riluzole of glycinergic postsynaptic currents in rat hypoglossal motoneurones. Br J Pharmacol. 1995;116:3227&#x2013;3230. doi: 10.1111/j.1476-5381.1995.tb15128.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.1995.tb15128.x</ArticleId><ArticleId IdType="pmc">PMC1909188</ArticleId><ArticleId IdType="pubmed">8719800</ArticleId></ArticleIdList></Reference><Reference><Citation>Zona C, Cavalcanti S, De Sarro G, et al. Kainate-induced currents in rat cortical neurons in culture are modulated by riluzole. Synapse. 2002;43:244&#x2013;251. doi: 10.1002/syn.10040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.10040</ArticleId><ArticleId IdType="pubmed">11835519</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli E, Funicello M, Rauen T, et al. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur J Pharmacol. 2008;578:171&#x2013;176. doi: 10.1016/j.ejphar.2007.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2007.10.023</ArticleId><ArticleId IdType="pubmed">18036519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK. Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs. Med Res Rev. 2019;39:733&#x2013;748. doi: 10.1002/med.21528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>